bio CDMO
Scope
Date
~
-
Bio & Pharma
LegoChem Bio, Janssen sign $1.7 bn ADC licensing deal
LegoChem Biosciences Inc. has signed a blockbuster $1.7 billion deal to license out its proprietary antibody drug conjugate (ADC) candidate to Jasse...
Dec 26, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s GC Cell targets global cell therapy CDMO business
GC Cell Corp., an affiliate of South Korea’s major pharmaceutical company GC Biopharma Corp., is targeting the cell therapy contract developme...
Dec 12, 2023 (Gmt+09:00)
-
Corporate strategy
Samsung launches new growth engine control tower at mobile division
Samsung Electronics Co., the world’s largest maker of memory chips and smartphones, has created a business control tower within its Digital eX...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio mulls name change after defeat to Lego
South Korean biopharmaceutical company LegoChem Biosciences Inc. is seeking to change its name after it lost in a trademark infringement lawsuit fil...
Dec 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Access Bio opens second plant in New Jersey
The US-based in-vitro diagnostic device company Access Bio Inc. announced on Monday that it opened its second factory in Monroe Township, New Jersey...
Dec 04, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea to invest $200 mn in new drugs, vaccines by 2028
South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco launches new viral vector platforms, key for CGT
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), has recently introduced two...
Nov 22, 2023 (Gmt+09:00)
-
Batteries
LG Chem, SNU to jointly develop next-generation material
South Korea's LG Chem Ltd. partnered with Seoul National University (SNU) to develop next-generation material technologies, including pivotal materi...
Nov 17, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Nov 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Engineering secures $349 mn bio plant deal
South Korea's Samsung Engineering secured a deal for the Songdo Bio Raw Material Plant construction project from the global life sciences and labora...
Nov 01, 2023 (Gmt+09:00)
-
Carbon neutrality
HD Hyundai Oilbank secures bio-based material supply network
South Korea's HD Hyundai Oilbank announced on Tuesday it signed contracts with Indonesia's Korindo Group and Korea's LX International for the purcha...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics partners with Europe's largest VC
Samsung Biologics Co., the world's largest contract drug manufacturer, announced on Tuesday it has teamed up with global biotech venture capitalist ...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Johnson & Johnson more interested in Korean bio startups
Johnson & Johnson, a global pharmaceutical giant, showed more interest in South Korean bio startups with competitive innovation despite the rece...
Oct 17, 2023 (Gmt+09:00)
-
Carbon neutrality
SK to invest in S.Korean company for bio jet fuel materials
SK Group, South Korea’s energy-to-semiconductor conglomerate, is set to invest in a local renewable energy ingredient provider for stable proc...
Oct 17, 2023 (Gmt+09:00)
-
Chemical Industry
LG Chem, GS Caltex form eco-friendly materials alliance
LG Chem Ltd. and GS Caltex Corp. are accelerating their efforts in the eco-friendly bio-material business involving 3-hydroxypropionic acid (3HP). 3...
Oct 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics to break ground on 1st local CDMO plant in 2024
South Korea’s Lotte Biologics Co. is set to start building its first local facility for drug manufacturing next year, aiming for 400,000 liter...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
CJ CheilJedang searches for global bio talent in Boston
South Korean food and bio giant CJ CheilJedang Corp. on Monday said its Chief Technology Officer Hwang Yun-il, CJ CheilJedang BIO executive Yoon Seo...
Sep 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biologics partners with Indian company for CDMO
Prestige Biologics Co., a South Korean biopharmaceutical contract development and manufacturing organization (CDMO) company, is expanding its CDMO b...
Sep 22, 2023 (Gmt+09:00)
-
Chemical Industry
Lotte Chemical launches eco-friendly material brand Ecoseed
South Korea's Lotte Chemical Corp. has launched its eco-friendly material brand, "Ecoseed." The company announced on Tuesday that it unveiled the Ec...
Sep 19, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
IMM PE invites potential buyers for Genuone worth $752 mn
South Korea’s top-tier contract drugmaker Genuone Sciences Inc. with an estimated value of up to 1 trillion won ($752 million) is smooth saili...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell Bio's treatment shows promise for advanced liver cancer
South Korea's VaxCell Biotherapeutics Co. on Tuesday said its treatment for advanced liver cancer under development stopped or greatly reduced the g...
Sep 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Wellmarker Bio signs worth of $528 mn tech transfer deal
Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...
Sep 12, 2023 (Gmt+09:00)
-
KOREA Investment Week
Celltrion builds clinical data bank for new biosimilars
The use of data and computing is a new paradigm in the biopharmaceutical industry, reducing the new drug development time and cost, Celltrion Inc. C...
Sep 12, 2023 (Gmt+09:00)
-
Corporate strategy
LG Group accelerates shift toward AI, bio and clean tech
Artificial intelligence, bio and clean tech are in their early stages of development for LG Group, but they should lead the South Korean conglomerat...
Aug 24, 2023 (Gmt+09:00)
-
Bio & Pharma
DongKoo Bio & Pharma to enter Philippine healthcare market
South Korea’s DongKoo Bio & Pharma Co. on Tuesday said it signed a memorandum of understanding with the Philippine healthcare group Adizat...
Aug 23, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Pharmteco gears up for big leap in advanced biotherapies
SK Pharmteco Co., South Korean conglomerate SK Group’s contract development and manufacturing organization (CDMO), is upping the ante in its b...
Aug 17, 2023 (Gmt+09:00)
-
KOREA Investment Week
S.Korea's largest investment forum to begin Sept. 11
South Korea’s largest investment conference will be held in Seoul Sept. 11-15 with around 100 chief executives from global financial services ...
Aug 10, 2023 (Gmt+09:00)